Yuman Fong, MD, discusses the evolution of colorectal liver metastases management from historical neglect to multimodal ...
The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...
The dyad model fosters collaboration between academic specialists and community oncologists, ensuring seamless patient care ...
Michael David Chuong, MD, discusses how SBRT has become a leading option for treating patients with colorectal liver ...
Gastrointestinal (GI) Cancers Symposium, Dani Castillo, MD, medical oncologist, City of Hope, shared new research titled, “Impact of metastatic sites and Lauren subtype on survival outcomes of ...